Additional, ALDH8A1, ALDOB and FAM110C are expected to be potential biomarkers of HCC, though further experimental verification is needed to confirm their potential prognostic value in HBV-positive HCC. The gene discussed is ALDOB; the disease is hepatocellular carcinoma.